Sagimet Biosciences Inc. - Series A · NASDAQ:SGMT
Kemble George sold 350,987 Sagimet Biosciences Inc. - Series A shares (Form 4)
Traded Aug 14, 2026 · Filed Aug 17, 2026
On Aug 14, 2026, Kemble George (Director) sold 350,987 Sagimet Biosciences Inc. - Series A shares at US$10.23 for US$3.59M under a trading plan, leaving 62,161 shares. Filed Aug 17, 2026 (Form 4).
- Sold
- 350,987 shares
- Price
- US$10.23
- Value
- US$3.59M
- Holding after
- 62,161 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 14, 2026 | Series A Common Stock | Option exercise | 326,618 | US$6.36 | 388,779 | Direct |
| Aug 14, 2026 | Series A Common Stock | Option exercise | 24,369 | US$6.36 | 413,148 | Direct |
| Aug 14, 2026 | Series A Common Stock | Sale | 350,987 | US$10.23 | 62,161 | Direct |
Source
Related
- Sagimet Biosciences Inc. - Series A
- Kemble George
- Sagimet Biosciences Inc. - Series A shareholders
- Form 4 · Kemble George · Aug 12, 2026
- Form 4 · Kemble George · Jul 22, 2026
- Schedule 13G · Commodore Capital LP · Oct 7, 2026
- Schedule 13G · Balyasny Asset Management L.P. · Aug 14, 2026
- Schedule 13G · BlackRock, Inc. · Jul 30, 2026
- Form 4 · Happel David · Jul 22, 2026
- Form 4 · Rozek Elizabeth · Jul 22, 2026